Literature DB >> 25485537

Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.

Shuang Yu1, Chuanfang Liu1, Lanhua Li1, Tian Tian1, Min Wang1, Yu Hu2, Cunzhong Yuan3, Lei Zhang4, Chunyan Ji1, Daoxin Ma1.   

Abstract

T helper 17 (Th17) cells and regulatory T (Treg) cells, along with Th1 and Th2 cells, may contribute to the development of immune thrombocytopenia (ITP). The imbalance of Th17/Treg toward Th17 cells has been shown to play a pivotal role in the peripheral immune response. Notch signaling has been implicated in peripheral T-cell activation and effector cell differentiation. However, the role of Th17/Treg in the pathogenesis of ITP and the effect of Notch signaling on Th17/Treg imbalances remain largely elusive in ITP. In vitro, we treated peripheral blood mononuclear cells (PBMCs) from ITP and healthy controls with γ-secretase inhibitor (DAPT). Th17 cells and Treg cells were measured by flow cytometry and IL-17, IL-21, and IL-10 secretion by enzyme immunoassay technique. The mRNA expression of Ntoch1, Hes1, Hey1, RORγt, and Foxp3 was investigated by RT-PCR. Cell proliferation and apoptosis were determined by the Cell Counting Kit-8 and apoptosis detection kit. We demonstrated that DAPT was effective in inhibiting mRNA expression of Notch signaling molecules. In untreated cultured PBMCs from ITP patients, we observed elevated Th17 cell and IL-21 levels and RORγt mRNA expression, decreased Treg cells and Foxp3 mRNA expression, and an increased ratio of Th17/Treg and RORγt/Foxp3. After inactivating Notch signal by DAPT, Th17 cells and Th17/Treg ratio were dose dependently decreased and accompanied by the reduction of IL-17 in culture supernatants and RORγt mRNA expression in ITP patients. However, no significant difference was found for Treg cells and Foxp3 mRNA expression, RORγt/Foxp3 ratio, and IL-21 and IL-10 levels after DAPT treatment in ITP patients. We also present evidence that the effect of DAPT inhibition on the Th17 cell response was associated with downregulation of RORγt and IL-17 transcription using human in vitro polarization. In conclusion, our findings highlight the importance of Notch signaling in Th17/Treg imbalances in ITP. Inactivation of Notch signaling might be a potential immunoregulatory strategy in ITP patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25485537     DOI: 10.1038/labinvest.2014.142

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  46 in total

1.  TCR-mediated Notch signaling regulates proliferation and IFN-gamma production in peripheral T cells.

Authors:  Tanapat Palaga; Lucio Miele; Todd E Golde; Barbara A Osborne
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

2.  Up-regulation of gene related to anergy in lymphocytes is associated with Notch-mediated human T cell suppression.

Authors:  Alex M Kostianovsky; Lisa M Maier; Clare Baecher-Allan; Ana C Anderson; David E Anderson
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

3.  Transient inactivation of Notch signaling synchronizes differentiation of neural progenitor cells.

Authors:  Branden R Nelson; Byron H Hartman; Sean A Georgi; Michael S Lan; Thomas A Reh
Journal:  Dev Biol       Date:  2007-01-08       Impact factor: 3.582

4.  Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura.

Authors:  Daoxin Ma; Jianjian Dai; Xiaojuan Zhu; Shuxin Yan; Ping Zhao; Jingru Zhang; Yuanyuan Zhu; Jianzhi Sun; Jun Peng; Chunyan Ji; Ming Hou
Journal:  Ann Hematol       Date:  2009-07-15       Impact factor: 3.673

5.  Engagement of activated Notch signalling in collagen II-specific T helper type 1 (Th1)- and Th17-type expansion involving Notch3 and Delta-like1.

Authors:  Z Jiao; W Wang; H Xu; S Wang; M Guo; Y Chen; J Gao
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

6.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

7.  Notch 1 signaling regulates peripheral T cell activation.

Authors:  Todd N Eagar; Qizhi Tang; Michael Wolfe; Yiping He; Warren S Pear; Jeffrey A Bluestone
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

8.  Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.

Authors:  Ji Yang; Yiwei Chu; Xue Yang; Di Gao; Lubing Zhu; Xinrong Yang; Linlin Wan; Ming Li
Journal:  Arthritis Rheum       Date:  2009-05

9.  Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling.

Authors:  Miao-Tzu Huang; Yang-Shia Dai; Yu-Bin Chou; Yi-Hsiu Juan; Chih-Chiang Wang; Bor-Luen Chiang
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

10.  The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat.

Authors:  Nicolas Manel; Derya Unutmaz; Dan R Littman
Journal:  Nat Immunol       Date:  2008-05-04       Impact factor: 25.606

View more
  19 in total

1.  miR-106b-5p induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura through NR4A3/Foxp3 pathway.

Authors:  Jian-Qin Li; Jian-Mei Tian; Xiao-Ru Fan; Zhao-Yue Wang; Jing Ling; Xiao-Fang Wu; Fei-Yun Yang; Ya-Lin Xia
Journal:  Cell Cycle       Date:  2020-04-23       Impact factor: 4.534

2.  Laboratory Investigation web focus on China.

Authors:  Catherine M Ketcham; Akihiro Umezawa; Hejian Zou; Gene P Siegal
Journal:  Lab Invest       Date:  2016-11       Impact factor: 5.662

3.  Circulating level of Th17 cells is associated with sensitivity to glucocorticoids in patients with immune thrombocytopenia.

Authors:  YiChan Zhang; TingTing Ma; Xuan Zhou; JunHao Chen; Juan Li
Journal:  Int J Hematol       Date:  2018-01-11       Impact factor: 2.490

4.  TGF-β-induced CD4+ FoxP3+ regulatory T cell-derived extracellular vesicles modulate Notch1 signaling through miR-449a and prevent collagen-induced arthritis in a murine model.

Authors:  Jingrong Chen; Feng Huang; Yuluan Hou; Xiaorong Lin; Rongzhen Liang; Xiaojiang Hu; Jun Zhao; Julie Wang; Nancy Olsen; Song Guo Zheng
Journal:  Cell Mol Immunol       Date:  2021-09-23       Impact factor: 11.530

Review 5.  Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.

Authors:  Shi-Yang Guan; Rui-Xue Leng; Muhammad Imran Khan; Humera Qureshi; Xiang-Pei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

6.  Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis.

Authors:  Hua Rong; Hongjie Shen; Yueli Xu; Hai Yang
Journal:  Immunology       Date:  2016-09-23       Impact factor: 7.397

Review 7.  The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Zorica Janjetovic; Tae-Kang Kim; Radomir M Slominski; Robert C Tuckey; Rebecca S Mason; Anton M Jetten; Purushotham Guroji; Jörg Reichrath; Craig Elmets; Mohammad Athar
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  Inhibiting the Notch signaling pathway suppresses Th17-associated airway hyperresponsiveness in obese asthmatic mice.

Authors:  Zeyu Zeng; Lei Wang; Weihui Ma; Rongying Zheng; Hong Zhang; Xinxin Zeng; Hui Zhang; Weixi Zhang
Journal:  Lab Invest       Date:  2019-08-13       Impact factor: 5.662

9.  Regulation of Th1/Th2 and Th17/Treg by pDC/mDC imbalance in primary immune thrombocytopenia.

Authors:  Qinzhi Li; Yang Liu; Xiujuan Wang; Mingling Sun; Lei Wang; Xinyou Wang; Ying Liu; Wenxia Fan; Kaile Zhang; Xiao Sui; Xinhong Guo
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-02

10.  Biomarkers for immune thrombocytopenia.

Authors:  Chunmei Zhang; Liping Zhang; Lingjia Yu; Yongyu Shi; Xuebin Ji
Journal:  Biomark Res       Date:  2015-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.